Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

which could be a concern for those interested in Zepbound. A spokesperson from Eli Lilly addressed this issue. “Today we are able to meet demand, but realize we will face challenges. We do our ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...